Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
In Vivo (Athens, Greece)|April 28, 2026
Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial CarcinomaKayo Kikuchi, Yuki Kobari, Kazutaka Nakamura, et al.
Kidney International Reports|September 14, 2019
In Vivo Expression of NUP93 and Its Alteration by NUP93 Mutations Causing Focal Segmental GlomerulosclerosisTaeko Hashimoto, Yutaka Harita, Keiichi Takizawa, et al.
Pathology International|March 30, 2021
Monoclonal and polyclonal immunoglobulin G deposits on tubular basement membranes of native and pretransplant kidneys: A retrospective studyAnri Sawada, Masayoshi Okumi, Shigeru Horita, et al.
Planta|February 22, 2023
Targeted expression of bgl23-D, a dominant-negative allele of ATCSLD5, affects cytokinesis of guard mother cells and exine formation of pollen in Arabidopsis thalianaMd Firose Hossain, Amit Kumar Dutta, Takamasa Suzuki, et al.
Cancer Diagnosis & Prognosis|September 3, 2025
Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case ReportTakafumi Mizuno, Yuki Kobari, Haruka Ito, et al.
In Vivo (Athens, Greece)|August 19, 2021
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell CarcinomaMaki Yoshino, Hiroki Ishihara, Yudai Ishiyama, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2005
Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patientsTokuyuki Kitahara, Kumeo Ono, Akiyasu Tsuchida, et al.
Scientific Reports|July 2, 2025
Personalized prediction model generated with machine learning for kidney function one year after living kidney donationRikako Oki, Toshihio Hirai, Kazuhiro Iwadoh, et al.
Clinical and Experimental Nephrology|December 18, 2025
Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end-stage renal disease populationsNanaka Katsurayama, Hiroki Ishihara, Toshihito Hirai, et al.
Transplantation Proceedings|March 21, 2021
Living-Donor Kidney Transplantation Performed in a Low-Volume Center by Visiting Surgeons From a High-Volume Center and Managed Clinically Solely by Nephrologists: 1-Year OutcomesMinoru Murakami, Hideki Ishida, Kazuki Yanagisawa, et al.
Pageof 30